'Marvel's Cloak & Dagger" has been cancelled by Freeform after two seasons.
This decision comes five months after the superhero series aired its second season finale.
"We are so proud of 'Marvel's Cloak & Dagger' and the trailblazing stories this series told. We are also grateful to our incredible talent Olivia Holt and Aubrey Joseph for bringing these beloved characters to life, and showrunner Joe Pokaski for his vision.
"We'd like to thank our partners at Marvel Television for a wonderful two seasons and are we are hopeful that we can find another project together," Freeform said in a statement to Entertainment Weekly.
The New Orleans-set series debuted in 2018 and followed Tandy/Dagger (Holt) and Tyrone/Cloak (Joseph), two teenagers from different backgrounds who realized an accident from their childhoods connected them and gave them superpowers.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app